Un programme d’éducation thérapeutique pour l’initiation et le suivi d’un traitement par clozapine

Abstract

Clozapine is the reference treatment for resistant schizophrenia. Although its efficacy has been widely demonstrated in numerous studies, it remains largely under-prescribed in its main indication. Therapeutic patient education (TPE) programs focused on clozapine could, on the one hand, promote the prescription of this drug and, on the other, encourage patients to adhere to the treatment schedule by improving their knowledge of its effectiveness. This article presents the TPE program entitled “Living with clozapine” developed to support the initiation and follow-up of patients being treated with clozapine.